Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Colorcon
AstraZeneca
Merck
McKinsey

Last Updated: May 26, 2022

Nesher Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NESHER PHARMS, and what generic and branded alternatives to NESHER PHARMS drugs are available?

NESHER PHARMS has thirty-three approved drugs.



Summary for Nesher Pharms
US Patents:0
Tradenames:24
Ingredients:22
NDAs:33

Drugs and US Patents for Nesher Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION;ORAL 076982-001 May 24, 2005 DISCN No No See Plans and Pricing See Plans and Pricing
Nesher Pharms MICRO-K 10 potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-002 May 14, 1984 DISCN Yes No See Plans and Pricing See Plans and Pricing
Nesher Pharms HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate SOLUTION;ORAL 040366-001 Jan 23, 2002 DISCN No No See Plans and Pricing See Plans and Pricing
Nesher Pharms DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 210080-004 Jul 17, 2019 DISCN No No See Plans and Pricing See Plans and Pricing
Nesher Pharms BENZONATATE benzonatate CAPSULE;ORAL 040795-002 Oct 31, 2007 DISCN No No See Plans and Pricing See Plans and Pricing
Nesher Pharms DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 075609-001 Oct 18, 2000 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Nesher Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Nesher Pharms MICRO-K potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-001 Approved Prior to Jan 1, 1982 4,259,315 See Plans and Pricing
Nesher Pharms MICRO-K 10 potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-002 May 14, 1984 4,259,315 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Colorcon
Baxter
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.